Skip to main content

4 Result(s)

within Li-Na Tang Remove this filter Hematology Remove this filter

and

  1. No Access

    Article

    Evaluation of pirarubicin–cisplatin chemotherapy in the treatment for refractory and recurrent high-grade osteosarcoma: experience of a single institute

    The purpose of this study was to investigate the feasibility and efficacy of pirarubicin (THP)–cisplatin (DDP) chemotherapy for refractory and recurrent high-grade osteosarcoma. Between 2008 and 2010, 23 patie...

    Wei-**ang Qi, Ai-Na He, Li-Na Tang, Zan Shen, Yang Yao in Medical Oncology (2012)

  2. No Access

    Article

    Effectiveness and safety of pemetrexed-based doublet versus pemetrexed alone as second-line treatment for advanced non-small-cell lung cancer: a systematic review and meta-analysis

    To compared pemetrexed-based doublet with single-agent pemetrexed as second-line treatment for advanced non-small-cell lung cancer

    Wei-**ang Qi, Li-Na Tang, Ai-Na He, Zan Shen… in Journal of Cancer Research and Clinical On… (2012)

  3. No Access

    Article

    Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcoma

    The present study was designed to determine whether the expression of chemokine receptor CXCR4 and vascular endothelial growth factor (VEGF) is correlated with the extent of metastasis and the survival of pati...

    Feng Lin, Shui-er Zheng, Zan Shen, Li-na Tang, ** Chen, Yuan-jue Sun… in Medical Oncology (2011)

  4. No Access

    Article

    Down-regulation of ribosomal protein L7A in human osteosarcoma

    To explore the expression of ribosomal protein L7A (RPL7A) in osteosarcoma and its correlation with clinical features.

    Shui-er Zheng, Yang Yao, Yang Dong, Feng Lin… in Journal of Cancer Research and Clinical On… (2009)